Sources | Names Used |
---|---|
CTRPv2 | decitabine:carboplatin (1:1 mol/mol) |
PharmacoGx | decitabine:carboplatin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RERGL | CTRPv2 | pan-cancer | AAC | 0.081 | 0.003 |
mRNA | ZHX3 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.003 |
mRNA | NAP1L1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.003 |
mRNA | WDR1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.003 |
mRNA | CDC42EP3 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.003 |
mRNA | ANKRD54 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.003 |
mRNA | CTD-2369P2.10 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.003 |
mRNA | TCTN3 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.003 |
mRNA | TGIF2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
mRNA | SPINK2 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.003 |